Navigation Links
U.S Shows Increased Obesity Rate

The U.S. obesity prevalence increased from 13 percent to 32 percent between the 1960s and 2004, according to researchers at the Johns Hopkins Bloomberg School of Public Health Center for Human Nutrition. The prevalence of obesity and overweight has increased at an average rate of 0.30.8 percentage points across different sociodemographic groups over the past three decades.

Some minority and low socioeconomic status groupssuch as non-Hispanic black women and children, Mexican-American women and children, low socioeconomic status black men and white women and children, Native Americans and Pacific Islandersare disproportionately affected.

The obesity rate in the United States has increased at an alarming rate over the past three decades. We set out to estimate the average annual increase in prevalence as well as the variation between population groups to predict the future situation regarding obesity and overweight among U.S. adults and children, said Youfa Wang, MD, PhD, lead author of the study and an assistant professor in the Bloomberg School of Public Healths Department of International Health. Obesity is a public health crisis.

If the rate of obesity and overweight continues at this pace, by 2015, 75 percent of adults and nearly 24 percent of U.S. children and adolescents will be overweight or obese.

The study authors included 20 journal papers, reports and online data sets in their meta-analysis. In addition, data from four national surveysNHANES, BRFSS, Youth Risk Behavior Surveillance System and National Longitudinal Survey of Adolescent Healthwere included in order to examine the disparities in obesity.

They defined adult overweight and obesity using body mass index cutoffs of 25 and 30, respectively. Children at risk for overweight and overweight were classified as being in the 85th and 95th percentiles of body mass index, respectively. The key findings include:

66% of U.S. adults were overw
'"/>




Page: 1 2

Related medicine news :

1. Experimental treatment for Ebola Virus Shows promising results in mice
2. New Prostate Cancer Vaccine Shows Promise
3. Ebola Treatment Shows Promise
4. New Drug Shows Significant Improvement In HIV-related Heart Condition
5. Greek Study Shows Living In The Hills May Be Healthier
6. Research Shows Carbon Monoxide Prevents Inflammations
7. Latest Research Shows That Multivitamins Might Not Prevent Infections In All Elderly
8. Novartis MS Drug Shows Promising Results
9. MRI Shows Emotional Changes During Menstrual Cycle
10. Bronchiolo-alveolar Carcinoma Shows Sonographic Pattern Of Pneumonia
11. AIDS drug GS 9137 Shows Promise
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Shows Increased Obesity Rate

Other Medicine News:Health News:Torchmark Corporation Declares Dividend 2Health News:America's Pending Shortage of Cancer Doctors 2Health News:America's Pending Shortage of Cancer Doctors 3Health News:Preeclampsia Might Protect Against Testicular Cancer 2Health News:Preeclampsia Might Protect Against Testicular Cancer 3Health News:New Online Support Site Offers Hope, Information, and Help for Patients Who Have Suffered a Catastrophic Injury 2Health News:Media Affects Public Perception of Infectious Diseases 2Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 2Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 3Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 4Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 5Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 6Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 7Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 8Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 9Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 10Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 11Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 12Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 13Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 14Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 15Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 16Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 17Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 18Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 19Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 20Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 21Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 22Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 23Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 24Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 25Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 26Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 27Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 28Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 29
Breaking Medicine Technology:ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 2ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 3ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 4VidaySalud.com(TM) Reaches 1,000,000 Page Views In its First Six Months of Operation 2Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 7Qforma Appoints Erin McLaughlin as Director Field Operations 5834 1Qforma Appoints Erin McLaughlin as Director Field Operations 5834 2Webcast Alert 3A Transgenomic Inc Announces Third Quarter 2009 Earnings Release Conference Call Webcast 5832 1Webcast Alert 3A Transgenomic Inc Announces Third Quarter 2009 Earnings Release Conference Call Webcast 5832 2High Resolution Breast PET Improves Breast Cancer Detection 5830 1High Resolution Breast PET Improves Breast Cancer Detection 5830 2High Resolution Breast PET Improves Breast Cancer Detection 5830 3